person

Jacmine P.

Country
France
Department
Service ophtalmologie Centre d’Investigations Cliniques

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 17 partner sites.

Specializations

Oncology – Advanced Solid Tumors

Focus on innovative therapies for high‑risk solid malignancies across multiple organ sites, emphasizing biomarker‑driven treatment selection.

  • Targeted agents for non‑small cell lung cancer
  • Combination regimens in metastatic breast cancer
  • Immunotherapy approaches for renal cell carcinoma
  • Precision medicine in pancreatic ductal adenocarcinoma
  • Therapeutic options for mesothelioma

These efforts aim to expand therapeutic options for patients with refractory or relapsed disease.

Hematology – Blood‑Based Malignancies

Investigation of novel agents for hematologic cancers, with an emphasis on overcoming resistance to standard chemotherapy.

  • Targeted therapy for acute myeloid leukemia
  • Immunomodulatory strategies in multiple myeloma
  • CAR‑T and bispecific approaches for acute lymphoblastic leukemia
  • Novel inhibitors for myelodysplastic syndromes
  • Management of chronic lymphocytic leukemia

Research supports the development of therapies that address high‑risk cytogenetic profiles.

Autoimmune & Inflammatory Disorders

Exploration of disease‑modifying treatments for systemic autoimmune conditions, targeting key inflammatory pathways.

  • IL‑6 inhibition in systemic lupus erythematosus
  • Targeted therapy for ANCA‑associated vasculitis
  • Biologic agents in psoriatic arthritis
  • Novel approaches for immune thrombocytopenia
  • Therapeutics for granulomatosis with polyangiitis

These projects aim to improve disease control while minimizing long‑term toxicity.

Cardiovascular & Metabolic Therapeutics

Clinical evaluation of interventions for cardiovascular disease and metabolic dysregulation, focusing on risk reduction and organ protection.

  • Anti‑inflammatory strategies in atherosclerotic cardiovascular disease
  • Novel agents for heart failure with reduced ejection fraction
  • Therapies targeting type 2 diabetes mellitus
  • Management of acute myocardial infarction
  • Prevention of stroke recurrence

Research seeks to integrate metabolic control with cardiovascular outcome improvement.

Neurology – Neurodegenerative & Neuroinflammatory Conditions

Advancement of treatments for neurodegenerative diseases and related neuroinflammatory disorders.

  • Targeted therapies for Alzheimer’s disease
  • Immunomodulation in multiple sclerosis
  • Neuroprotective agents for Parkinson’s disease
  • Management of neuromyelitis optica spectrum disorder
  • Therapeutic options for amyotrophic lateral sclerosis

Efforts prioritize slowing disease progression and preserving functional capacity.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.